The AML Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

What’s next in AML?

Sep 25, 2020

During the 2020 Annual Meeting of the Society of Hematologic Oncology (SOHO), the AML Hub was pleased to speak to Amer Zeidan, Yale School of Medicine, New Haven, US. We asked: What's next in AML?

What’s next in AML?

Amer Zeidan discusses the future directions in the management of AML, and highlights the progress that has been made in the past decade. In the US, nine novel agents have been approved for the treatment of AML over the past 3 years and here, Amer Zeidan outlines the impact he thinks these agents will have on the treatment approach to AML.